Development of new or worsening headache after cochlear implant activation: A hypothesis-generating pilot study of incidence, timing, and clinical factors

Q3 Medicine Cephalalgia Reports Pub Date : 2020-08-24 DOI:10.1177/2515816320951820
Nina Riggins, Ricky Chae, M. Levin, Annika Ehrlich, Henna Sawhney, Colleen Polite, P. Goadsby
{"title":"Development of new or worsening headache after cochlear implant activation: A hypothesis-generating pilot study of incidence, timing, and clinical factors","authors":"Nina Riggins, Ricky Chae, M. Levin, Annika Ehrlich, Henna Sawhney, Colleen Polite, P. Goadsby","doi":"10.1177/2515816320951820","DOIUrl":null,"url":null,"abstract":"The objectives of the study are to investigate the incidence of new or worsening headache after cochlear implant (CI) surgery and activation and to determine whether there are predictors of associated headache. We performed a cross-sectional survey of patients who had CI surgery. The frequency and severity of headache, onset of headache relative to surgery and device activation, medication use, family history, headache triggers, and accompanying cranial autonomic symptoms were recorded and analyzed. Thirty-seven subjects were enrolled. In the time period after CI surgery but before CI activation, none reported a new headache and four (11%) reported a worsening headache. After CI activation, six (16%) developed new headache and five (14%) developed worsening headache. These 11 subjects also experienced a significantly higher mean of 6.3 headache days/month following CI activation (p < 0.009). Providers should be aware that new or worsening headache can be reported following CI activation, although not immediately following CI surgery.","PeriodicalId":9702,"journal":{"name":"Cephalalgia Reports","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2515816320951820","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cephalalgia Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/2515816320951820","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

The objectives of the study are to investigate the incidence of new or worsening headache after cochlear implant (CI) surgery and activation and to determine whether there are predictors of associated headache. We performed a cross-sectional survey of patients who had CI surgery. The frequency and severity of headache, onset of headache relative to surgery and device activation, medication use, family history, headache triggers, and accompanying cranial autonomic symptoms were recorded and analyzed. Thirty-seven subjects were enrolled. In the time period after CI surgery but before CI activation, none reported a new headache and four (11%) reported a worsening headache. After CI activation, six (16%) developed new headache and five (14%) developed worsening headache. These 11 subjects also experienced a significantly higher mean of 6.3 headache days/month following CI activation (p < 0.009). Providers should be aware that new or worsening headache can be reported following CI activation, although not immediately following CI surgery.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人工耳蜗激活后新发或恶化头痛的发展:一项关于发病率、时间和临床因素的假设产生的初步研究
本研究的目的是调查人工耳蜗(CI)手术和激活后新发头痛或加重头痛的发生率,并确定是否存在相关头痛的预测因子。我们对接受CI手术的患者进行了横断面调查。记录和分析头痛的频率和严重程度、与手术和器械激活相关的头痛发作、药物使用、家族史、头痛触发因素和伴随的颅自主神经症状。37名受试者入组。在CI手术后但CI激活前的时间段内,没有人报告新的头痛,4人(11%)报告头痛恶化。CI激活后,6例(16%)出现新的头痛,5例(14%)头痛恶化。这11名受试者在CI激活后平均头痛天数6.3天/月显著增加(p < 0.009)。提供者应该意识到新的或恶化的头痛可以在CI激活后报告,尽管不是在CI手术后立即报告。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cephalalgia Reports
Cephalalgia Reports Medicine-Neurology (clinical)
CiteScore
2.50
自引率
0.00%
发文量
17
审稿时长
9 weeks
期刊最新文献
Protocol of a cross-sectional, multicentre and multidisciplinary study describing phenotype and burden of a midfacial segment pain Paranoid psychosis after a single parenteral dose of indomethacin administered for headache diagnosis: A case and review of the literature Extended regular use of kinetic oscillation stimulation (KOS) in refractory chronic migraine: case report of a first, single-subject experience Corrigendum to “Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies” A century of bruxism research in top-ranking medical journals
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1